Home » NutraCea Granted Patent on Proprietary Formula for Arthritis, Joint Treatment
NutraCea Granted Patent on Proprietary Formula for Arthritis, Joint Treatment
NutraCea has been issued a patent from the U.S. Patent and Trademark Office titled, "Methods for Treating Joint Inflammation, Pain and Loss of Mobility."
The patent contains 14 claims, which include a method for treating lameness, pain and loss of mobility in humans and mammals, and a method for inhibiting prostaglandin synthetase activity, which is also known as Cox-2 inhibition.
NutraCea is a dietary supplement maker working to develop natural formula alternatives to the current generation of pharmaceutical Cox-2 inhibitors.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct